Zobrazeno 1 - 10
of 203
pro vyhledávání: '"Bernard, MJ."'
Autor:
Chery MJ, Baral A, Rolle LD, Abdshah A, Bernard MJ, Poudel L, Francois L, Jones DL, Jean-Louis G, Blanc J
Publikováno v:
Nature and Science of Sleep, Vol Volume 16, Pp 17-31 (2024)
Maurice Junior Chery,1 Amrit Baral,1 LaShae D Rolle,1 Alireza Abdshah,1 Maritza J Bernard,2 Laxmi Poudel,3 Laura Francois,1 Deborah L Jones,4 Girardin Jean-Louis,4 Judite Blanc4 1Department of Public Health Sciences, the University of Miami Miller Sc
Externí odkaz:
https://doaj.org/article/d8a524f982f04754b3a45038b61bce29
Autor:
Rouvière, N., Chkair, S., Auger, F., Alovisetti, C., Bernard, MJ., Cuvillon, P., Kinowski, J-M., Leguelinel-Blache, G., Chasseigne, V.
Publikováno v:
In International Journal of Surgery May 2022 101
Autor:
van Lierop, Zoë YGJ, Wessels, Mark HJ, Lekranty, Womei ML, Moraal, Bastiaan, Hof, Sam N, Hogenboom, Laura, de Jong, Brigit A, Meijs, Nandi, Mensing, Liselore A, van Oosten, Bob W, Sol, Nik, van Kempen, Zoé LE, Vermunt, Lisa, Willems, Myrthe J, Strijbis, Eva MM, Uitdehaag, Bernard MJ, Killestein, Joep, Teunissen, Charlotte E
Publikováno v:
Multiple Sclerosis Journal; Nov2024, Vol. 30 Issue 13, p1620-1629, 10p
Autor:
Krijnen, Eva A, Kouwenhoven, Rose-Marie, Noteboom, Samantha, Barkhof, Frederik, Uitdehaag, Bernard MJ, Klawiter, Eric C, Steenwijk, Martijn D, Schoonheim, Menno M, Koubiyr, Ismail
Publikováno v:
Multiple Sclerosis Journal; Oct2024, Vol. 30 Issue 11/12, p1556-1560, 5p
Autor:
Coerver, Eline ME, Kaçar, Sezgi, Ciccarelli, Olga, Sormani, Maria P, Barkhof, Frederik, Arnold, Douglas L, Schoonheim, Menno M, Van Kempen, Zoé LE, Mostert, Jop, Koch, Marcus W, Killestein, Joep, Eshaghi, Arman, Uitdehaag, Bernard MJ, Strijbis, Eva MM
Publikováno v:
Multiple Sclerosis Journal; Sep2024, Vol. 30 Issue 10, p1296-1308, 13p
Autor:
Zoë YGJ van Lierop, Samantha Noteboom, Martijn D Steenwijk, Maureen van Dam, Alyssa A Toorop, Zoé LE van Kempen, Bastiaan Moraal, Frederik Barkhof, Bernard MJ Uitdehaag, Menno M Schoonheim, Charlotte E Teunissen, Joep Killestein
Publikováno v:
Multiple Sclerosis Journal, 28(14), 2231-2242. SAGE Publications Ltd
van Lierop, Z Y GJ, Noteboom, S, Steenwijk, M D, van Dam, M, Toorop, A A, van Kempen, Z L E, Moraal, B, Barkhof, F, Uitdehaag, B M J, Schoonheim, M M, Teunissen, C E & Killestein, J 2022, ' Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis ', Multiple Sclerosis Journal, vol. 28, no. 14, pp. 2231-2242 . https://doi.org/10.1177/13524585221118676
van Lierop, Z Y GJ, Noteboom, S, Steenwijk, M D, van Dam, M, Toorop, A A, van Kempen, Z L E, Moraal, B, Barkhof, F, Uitdehaag, B M J, Schoonheim, M M, Teunissen, C E & Killestein, J 2022, ' Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis ', Multiple Sclerosis Journal, vol. 28, no. 14, pp. 2231-2242 . https://doi.org/10.1177/13524585221118676
Background: Despite highly effective treatment strategies for patients with relapsing-remitting multiple sclerosis (RRMS), long-term neurodegeneration and disease progression are often considerable. Accurate blood-based biomarkers that predict long-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c4fb71ef2aefb5779c059be4ffa4d20
https://doi.org/10.1177/13524585221118676
https://doi.org/10.1177/13524585221118676
Autor:
Leung, Melissa Wy, Bazelier, Marloes T, Souverein, Patrick C, Uitdehaag, Bernard Mj, Klungel, Olaf H, Leufkens, Hubert Gm, Pajouheshnia, Romin, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Leung, M W Y, Bazelier, M T, Souverein, P C, Uitdehaag, B M J, Klungel, O H, Leufkens, H G M & Pajouheshnia, R 2022, ' Mapping the risk of infections in patients with multiple sclerosis : A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum ', Multiple Sclerosis Journal, vol. 28, no. 11, pp. 1808-1818 . https://doi.org/10.1177/13524585221094218
Multiple Sclerosis Journal, 28(11), 1808-1818. SAGE Publications Ltd
Multiple sclerosis (Houndmills, Basingstoke, England), 28(11), 1808. SAGE Publications Ltd
Multiple Sclerosis Journal, 28(11), 1808-1818. SAGE Publications Ltd
Multiple sclerosis (Houndmills, Basingstoke, England), 28(11), 1808. SAGE Publications Ltd
Background: People with multiple sclerosis (pwMS) have an increased risk of infections; risk factors include underlying disease, physical impairment and use of some disease-modifying treatments. Objective: To quantify changes in population-level infe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42e7f4fa08bee00ee9014a0f056666d5
https://doi.org/10.1177/13524585221094218
https://doi.org/10.1177/13524585221094218
Autor:
Mattiesing, Rozemarijn M, Kramer, Eline, Strijbis, Eva MM, Brouwer, Iman, van Schijndel, Ronald A, Gentile, Giordano, Battaglini, Marco, De Stefano, Nicola, Uitdehaag, Bernard MJ, Barkhof, Frederik, Vrenken, Hugo, Schoonheim, Menno M
Publikováno v:
Multiple Sclerosis Journal; Jan2024, Vol. 30 Issue 1, p44-54, 11p
Autor:
Eva MM Strijbis, Pavle Repovic, Jop Mostert, James D Bowen, Bernard MJ Uitdehaag, Gary Cutter, Marcus W Koch
Publikováno v:
Multiple Sclerosis Journal, 28(10), 1606-1619. SAGE Publications Ltd
Strijbis, E M M, Repovic, P, Mostert, J, Bowen, J D, Uitdehaag, B M J, Cutter, G & Koch, M W 2022, ' The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials ', Multiple Sclerosis Journal, vol. 28, no. 10, pp. 1606-1619 . https://doi.org/10.1177/13524585221105465
Strijbis, E M M, Repovic, P, Mostert, J, Bowen, J D, Uitdehaag, B M J, Cutter, G & Koch, M W 2022, ' The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials ', Multiple Sclerosis Journal, vol. 28, no. 10, pp. 1606-1619 . https://doi.org/10.1177/13524585221105465
Background: Patient-reported outcome measures (PROMs) are often used in clinical research, but little is known about their performance as longitudinal outcomes. Methods: We used data from ASCEND, a large SPMS trial ( n = 889), to investigate changes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f884d134aaccd214afc529979b8d6d5c
http://www.scopus.com/inward/record.url?scp=85134989329&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85134989329&partnerID=8YFLogxK
Autor:
Wallace J Brownlee, Christian Wolf, Hans-Peter Hartung, Theo Dingermann, Nadia Anshasi, Richard AC Clark, Maria Trojano, Krzysztof Selmaj, Bernard MJ Uitdehaag, Carmen Tur, Jens Wuerfel, Gabriele Dallmann, Julian Witte, Martina Sintzel, Olga Bobrovnikova, Jeffrey A Cohen
Publikováno v:
Multiple Sclerosis Journal, 28(14), 2177-2189. SAGE Publications Ltd
Brownlee, W J, Wolf, C, Hartung, H-P, Dingermann, T, Anshasi, N, Clark, R A C, Trojano, M, Selmaj, K, Uitdehaag, B M J, Tur, C, Wuerfel, J, Dallmann, G, Witte, J, Sintzel, M, Bobrovnikova, O & Cohen, J A 2022, ' Use of follow-on disease-modifying treatments for multiple sclerosis : Consensus recommendations ', Multiple Sclerosis Journal, vol. 28, no. 14, pp. 2177-2189 . https://doi.org/10.1177/13524585221116269
Brownlee, W J, Wolf, C, Hartung, H-P, Dingermann, T, Anshasi, N, Clark, R A C, Trojano, M, Selmaj, K, Uitdehaag, B M J, Tur, C, Wuerfel, J, Dallmann, G, Witte, J, Sintzel, M, Bobrovnikova, O & Cohen, J A 2022, ' Use of follow-on disease-modifying treatments for multiple sclerosis : Consensus recommendations ', Multiple Sclerosis Journal, vol. 28, no. 14, pp. 2177-2189 . https://doi.org/10.1177/13524585221116269
Background: As patents for multiple sclerosis (MS) therapies expire, follow-on disease-modifying treatments (FO-DMTs) become available at reduced cost. Concerns exist that cheaper FO-DMTs are used simply to reduce healthcare costs. However, the well-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76c5b38de7215defadd844af514b4860
https://doi.org/10.1177/13524585221116269
https://doi.org/10.1177/13524585221116269